Tectonic Therapeutic (TECX)
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of...
- Open
- 30.000
- High
- 31.960
- Low
- 28.960
- Prev. Close
- 29.940
- Volume
- 156.09K
- Turnover
- 4.78M
- Avg Price
- 30.598
- Bid/Ask Ratio
- -98.06%
- Amplitude
- 10.02%
- 52wk High
- 39.528
- Volume Ratio
- 1.80
- Turnover Ratio
- 1.31%
Tectonic Therapeutic Analyst Rating
View moreForecast & Rating
Sep 1, 2026Price forecast
$77.56147.07%
Forecast & RatingStrong buy
10analysts
- Strong buy90.00%
- Buy10.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Aug 20 at 11:00 AM
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research
- PUBT · Aug 14 at 11:26 PM
Tectonic Therapeutic CSO Peter McNamara reports TECX common share disposal worth $1,505 on Aug. 12
- Market Beat · Aug 7 at 11:11 PM
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS
- Tip Ranks · Aug 7 at 03:28 PM
Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
